Assessment and comparison of recombinant proteins from different sources for the detection of SARS-CoV-2 infection by using protein microarray

Acta Biochim Biophys Sin (Shanghai). 2021 Feb 4;53(2):262-264. doi: 10.1093/abbs/gmaa152.

Authors

Huan Qi¹, Mingliang Ma¹, Danyun Lai¹, Yang Li¹, Fucheng Zhang², Sheng-Ce Tao¹

Affiliations

¹ Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
² Research and Development Department, Company ABclonal, Inc., Wuhan 430073, China.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunogenicity, Vaccine / immunology
Immunogenicity, Vaccine / physiology
Nucleocapsid / immunology
Protein Array Analysis / methods*
Recombinant Proteins / genetics
Recombinant Proteins / metabolism*
SARS-CoV-2 / immunology
SARS-CoV-2 / pathogenicity*

Substances

Recombinant Proteins